Cannabis Testing Market Expands as Regulatory Standards and Quality Assurance Drive Industry Growth
Growing emphasis on product safety, increasing regulatory oversight, and rising demand for standardized testing are accelerating growth in the cannabis testing market.
The global Cannabis Testing Market size was valued at USD 2.05 billion in 2024 and is expected to reach USD 2.42 billion by 2025. Looking ahead, the industry is projected to expand significantly, reaching USD 5.62 billion by 2030, registering a CAGR of 18.3% from 2025 to 2030.Β
Market growth is being supported by advances in analytical technologies, expansion of laboratory capabilities, and increasing demand for transparent quality validation processes. Organizations are investing in modern testing infrastructure, digital laboratory management systems, and standardized reporting practices to improve operational efficiency and strengthen compliance outcomes. Continued focus on laboratory accreditation, data reliability, and process standardization is further expanding opportunities across the market.
β’ Agilent Technologies Inc.
β’ SGS SA
β’ Hamilton Company
β’ Eurofins Scientific
β’ Shimadzu Corporation
β’ Waters Corporation
β’ Merck
β’ MCS Inc.
β’ Thermo Fisher Scientific Inc.
β’ Restek Corporation
β’ SC Labs
β’ ProVerde Laboratories
β’ GREEN LEAF LAB
β’ ADACT Medical Ltd.
β’ AZ Biopharm GmbH
The market remains highly competitive as testing providers and analytical technology companies continue investing in advanced laboratory capabilities and quality focused solutions. Companies are emphasizing automation, precision analytics, scalable testing platforms, and validated methodologies to strengthen market positioning and support evolving compliance expectations.
Strategic collaborations, laboratory expansion initiatives, and investment in analytical innovation continue shaping industry competition globally. Market participants are focusing on data transparency, standardized reporting frameworks, and operational excellence to strengthen reliability and support long term market development.
The Cannabis Testing Market is expected to witness sustained long term growth as industries increasingly prioritize quality assurance, standardized analytical processes, and regulatory alignment. Continued investment in testing technologies, laboratory modernization, and data driven validation practices will remain central to shaping the future of this evolving analytical services market.